Jim Simons's position in Vertex Pharmaceuticals is currently worth $434 Million. That's 0.58% of their equity portfolio (26th largest holding). The first Vertex Pharmaceuticals trade was made in Q3 2013. Since then Jim Simons bought shares sixteen more times and sold shares on fourteen occasions. The stake costed the investor $274 Million, netting the investor a gain of 58% so far.